Project Number 5U01AG061357-04 Agency/Funding Organization NIA Funding Year 2021 View Full Project Details for AMP-AD Brain Proteomic Network Enhancement, Validation, and Translation into CSF Biomarkers Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category B. Diagnosis, Assessment, and Disease Monitoring 1. Fluid Biomarkers a. CSF Biomarkers Researcher and Organization Principal Investigator LEVEY, ALLAN I Principal Investigator First Name ALLAN Principal Investigator Last Name LEVEY Awardee Organization EMORY UNIVERSITY Awardee State Georgia Contact PI Country United States Project Detail Funding Opportunity Announcement RFA-AG-18-013: Continuation of the AMP-AD Target Discovery and Preclinical Validation Consortium (U01 Clinical Trial Optional) FY Overall Cost $1,418,315 Funding Organization Agency/Funding Organization NIA Funding Organization Country United States Program Official PETANCESKA, SUZANA Special Initiative Accelerating Medicines Partnership - Alzheimer's Disease (AMP-AD): Target Discovery and Preclinical Validation Project
